Premium
Rapamycin and tacrolimus differentially modulate acute graft‐versus‐host disease in rats after liver transplantation
Author(s) -
Xu Guodong,
Wang Linyan,
Chen Wei,
Xue Fei,
Bai Xueli,
Liang Liang,
Shen Xuning,
Zhang Mangli,
Xia Dajing,
Liang Tingbo
Publication year - 2010
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.22003
Subject(s) - foxp3 , medicine , tacrolimus , il 2 receptor , liver transplantation , peripheral blood mononuclear cell , flow cytometry , regulatory t cell , transplantation , sirolimus , immunology , gastroenterology , pharmacology , t cell , immune system , biology , in vitro , biochemistry
Acute graft‐versus‐host disease (aGVHD) is a serious complication of liver transplantation (LTx); it occurs in 1% to 2% of liver allograft recipients. The condition has a poor prognosis and poses major diagnostic and therapeutic challenges. A rat model of aGVHD after LTx has been developed, and a relative decrease in regulatory T (Treg) cells has been shown to be associated with this model. Interest has been expressed in the effects of different immunosuppressive agents on CD4+CD25+Foxp3+ Treg cell homeostasis. Rats with aGVHD after LTx were treated with tacrolimus (FK506), rapamycin (RAPA), or no immunosuppressive drug. Those that received RAPA survived longer (91.4 ± 8.1 days) than those in the FK506 group (62.3 ± 13.4 days) or the control group (22.9 ± 1.2 days). Flow cytometry analysis showed that Treg cells, as a percentage of peripheral blood mononuclear cells (PBMCs), were more abundant in the RAPA group (6.8% ± 0.8%) than in the FK506 group (1.7% ± 0.4%) or the control group (2.0% ± 0.4%). Immunohistochemistry demonstrated more Foxp3+ staining of intestinal cells in the RAPA group than in the FK506 group or the control group. In conclusion, the reduced mortality induced by RAPA in a rat model of aGVHD after LTx was associated with higher percentages of CD4+CD25+Foxp3+ Treg cells in PBMCs in blood and tissues than those occurring after the administration of FK506. Liver Transpl 16:357–363, 2010. © 2009 AASLD.